Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Direct-To-Consumer Television Advertising Marks The Tipping Point For Belviq Sales
Seeking Alpha
Monday, March 24, 2014 - 10:01am
tags:
Belviq, obesity, Eisai, drug ads, Arena Pharmaceuticals
Cancer Vaccines: Doomed to Fail?
Motley Fool
Monday, March 24, 2014 - 10:01am
tags:
cancer vaccines, Vical, Merck KGaA, GSK, MAGE-A3, Dendreon, Provenge, Stimuvax
FDA says Exact Sciences colorectal cancer screening tool study met objectives
Yahoo/Fly on the Wall
Monday, March 24, 2014 - 9:58am
tags:
FDA, colorectal cancer, EXACT Sciences, Cologuard
Israel's BrainStorm gets U.S. patent for stem cell technology
Yahoo/Reuters
Monday, March 24, 2014 - 8:53am
tags:
stem cells, BrainStorm Cell Therapeutics, Israel, patents
One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug
Forbes
Monday, March 24, 2014 - 8:52am
tags:
drug pricing, Henry Waxman, Sovaldi, Gilead Sciences
Bristol-Myers, Roche, working on possible blockbusters for melanoma, WSJ says
Yahoo/Fly on the Wall
Monday, March 24, 2014 - 8:50am
tags:
Bristol-Myers Squibb, Roche, melanoma, AstraZeneca
The Use and Misuse of Information Technology in Health Care: Several Doctors Reply
Yahoo/The Atlantic
Monday, March 24, 2014 - 8:35am
tags:
EMRs, electronic medical records, physicians
Big pharma balks at investment in TB
Financial Times
Monday, March 24, 2014 - 8:33am
tags:
tuberculosis, R&D, AstraZeneca, JNJ
FDA says it is recalling twice the medical devices it did a decade ago
Marketwatch
Monday, March 24, 2014 - 8:31am
tags:
FDA, devices, recalls
Biotech Rival to Teva Blockbuster Said to Seek IPO
Bloomberg
Sunday, March 23, 2014 - 10:08am
tags:
Teva Pharmaceuticals, Mapi Pharma, Copaxone
Empiriko’s ‘liver in a test tube’ could speed drug development
Beta Boston, MA
Sunday, March 23, 2014 - 10:02am
tags:
Empiriko
Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo/BusinessWire
Sunday, March 23, 2014 - 9:48am
tags:
Pfizer, tofacitinib, psoriasis
Sequenom and former CFO resolve litigation
Yahoo/The Fly on the Wall
Sunday, March 23, 2014 - 9:46am
tags:
Sequenom
3 Upcoming FDA Meetings You Should be Watching
Motley Fool
Sunday, March 23, 2014 - 9:45am
tags:
EXACT Sciences, Cologuard, Pfizer, dalbavancin, Cubist Pharmaceuticals, tedizolid phosphate
Novartis chairman stresses need for R&D investment
MarketWatch
Saturday, March 22, 2014 - 1:19pm
tags:
Novartis
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
The Pharma Letter
Saturday, March 22, 2014 - 12:46pm
tags:
Takeda, vedolizumab, Entyvio, ulcerative colitis, Crohn's Disease
Genentech wins FDA approval for Xolair to treat hives
San Francisco Chronicle, CA
Saturday, March 22, 2014 - 12:19pm
tags:
Genentech, Xolair, hives
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Saturday, March 22, 2014 - 12:10pm
tags:
JNJ, psoriasis, guselkumab
From Plant to Prescription: 5 Ways Marijuana Made It to the Market
Wall St Cheat Sheet
Saturday, March 22, 2014 - 11:49am
tags:
marijuana
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Saturday, March 22, 2014 - 11:48am
tags:
Gilead Sciences, hepatitis C, Sovaldi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.